ClinicalTrials.gg
RecruitingNCT04366531START-VETUpdated Oct 16, 2026

Successful Transitions and Reintegration Tools for Veterans (START-VETS)

An interventional study of START-VET and Treatment as usual in Substance Use Disorder, Mental Illness and Recently Incarcerated, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2020; still recruiting 6 years 3 months later.
Updated Oct 16, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 61 studies in Substance-Related Disorders by VA Office of Research and Development — 14 open to participants now, 16 under way, none of them phase 3. Substance-Related Disorders · VA Office of Research and Development.

Planned enrollment
56th of 59
20 · median 138
Started
2020
with 1 other
No phase
52 of 61
13 open now
Primary completion
2027-02
later than 2 of 15 live
Registered
39th of 61
by date

Among the 61 studies in Substance-Related Disorders by VA Office of Research and Development, this one is the 56th largest by planned enrollment of the 59 interventional ones that give a count, is one of 2 that started in 2020, is one of 52 with no phase, reaches primary completion later than 2 of the 15 other live ones, and was the 39th registered.

Substance-Related Disorders

2,242 studies on the registry are indexed under Substance-Related Disorders; 408 are open to participants now.

Browse Substance-Related Disorders studies →

Open to participants now

14 of the 61 studies in Substance-Related Disorders by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 266 Substance-Related Disorders studies recruiting now, 130 (49%) set no upper age limit and 117 (44%) stop at 75 or younger; 55 take children under 18; 90 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Substance-Related Disorders by VA Office of Research and Development, or all of them as a file.
02

Study summary

This study will develop prison reentry materials for Veterans leaving prison.

Read the detailed description

This study will be conducted in three phases:

Phase 1 is to collect qualitative data from Veterans who have recently been released from prison. The data will focus on their transition experience, stigma (both self and from others), and behaviors that interfered with success.

Phase 2a will be to develop a transition program based around the needs identified in phase 1 Phase 2b will be to develop assessment tools to be used with the program Phase 3 will be to perform a two group randomized cross over design pilot study to assess the program

03

Conditions studied

  • Substance Use Disorder
  • Mental Illness
  • Recently Incarcerated

Keywords

  • reentry
  • Mental illness
  • prison
  • substance use disorder
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veteran with mental illness and/or substance use disorder released from prison within the past 36 months

Exclusion criteria

Exclusion Criteria:

  • Psychosis or cognitive impairment precluding active participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • No intervention
    Monitoring/Treatment as usual

    Veterans will not receive any study related interventions.

  • Active comparator
    Reentry Program

    Veterans will receive the START-VET reentry program

    Behavioral: START-VET · Other: Treatment as usual

Interventions

  • BehavioralSTART-VET

    prison reentry program

  • OtherTreatment as usual

    This intervention involves no additional services above what is provided by the local health care system

06

What researchers measure

Primary outcomes

  1. Change in the Brief Symptom Inventory -18

    The Brief Symptom Inventory - 18 evaluates the domains of Somatization, Depression, and Anxiety. Each scale has 6 items, with a range of 0-24. Higher indicates a higher amount of the identified construct, i.e a worse outcome.

    Time frame: The Brief Symptom Inventory will be administered at the baseline of the subject's participation and again every 4 weeks for 16 weeks.

  2. Change in the World Health Organization Quality of Life 100

    The World Health Organization Quality of Life 100 is a overall measure quality of life for participants. It has 5 domains: Physical (12 items, range 12-60), Psychological (18 items, range 18-90), Independence (16 items, range 16 - 80), Social (12 items, range 12-60), Environment (32 items, range 32-160), and Spiritual (4 items, range 4-20). Higher indicates higher levels of quality of life.

    Time frame: The World Health Organization Quality of Live 100 will be administered at the baseline of the subject's participation and again every 4 weeks for 16 weeks.

  3. Inventory of Criminal Thinking Style

    The Inventory of Criminal Thinking Styles (PICTS) is an 80-item self-report inventory designed to measure eight thinking styles presumed to reinforce, support, and maintain a criminal lifestyle. The eight thinking styles assessed by the PICTS are Mollification, Cutoff, Entitlement, Power Orientation, Superoptimism, Sentimentality, Cognitive Indolence, and Discontinuity. There are 10 items on each scale with scale scores ranging from 0 - 30. Higher indicates worse outcomes

    Time frame: The Inventory of Criminal Thinking Style will be administered at the baseline of the subject's participation and again every 4 weeks for 16 weeks.

07

Study locations

1 of 1 sites recruiting
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
    Dallas, Texas 75216-7167, United States
    Recruiting
    • April Crawford, MS · Contactapril.crawford@va.gov · (214) 857-2571
    • James P. LePage, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2020 (actual). Primary completion is estimated for Feb 2027, 78 months after the start.

Of 819 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's planned 78 months is above that.

Counting every sponsor, half of 859 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Oct 2026 → Feb 2027 and completion Dec 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2020
First posted
Apr 29, 2020
StartActual
Aug 3, 2020
Primary completionEst.
Feb 5, 2027was Oct 2026
CompletionEst.
Jun 1, 2027was Dec 2026
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 2, 2026→Feb 5, 2027
Oct 16, 2026
Study completion
Dec 31, 2026→Jun 1, 2027
Oct 16, 2026
Show all 2 updates
  1. Oct 16, 2026
    Primary completion Oct 2, 2026→Feb 5, 2027
    Study completion Dec 31, 2026→Jun 1, 2027
    + 1 other change: verification date
  2. Sep 29, 2026
    Minor edits only
    + 6 other changes: identifiers, verification date, description, design details, criteria formatting and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04366531
Responsible party
Sponsor
First posted
Apr 29, 2020
Start date
Aug 3, 2020
Primary completion
Feb 5, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Oct 16, 2026

Study contacts

April Crawford, MS
Contact
april.crawford@va.gov
(214) 857-2571
James P. LePage, PhD
principal investigator · VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion